GVAG
XBI icon

Great Valley Advisor Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Great Valley Advisor Group’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$362K Buy
2,834
+254
+10% +$31.7K 0.01% 766
2025
Q4 		$314K Buy
2,580
+213
+9% +$24.4K 0.01% 768
2025
Q3 		$237K Sell
2,367
-125
-5% -$11.3K ﹤0.01% 845
2025
Q2 		$206K Sell
2,492
-258
-9% -$20.6K ﹤0.01% 860
2025
Q1 		$223K Sell
2,750
-129
-4% -$11.5K ﹤0.01% 805
2024
Q4 		$260K Sell
2,879
-535
-16% -$51.8K 0.01% 735
2024
Q3 		$337K Buy
3,414
+746
+28% +$73.3K 0.01% 657
2024
Q2 		$247K Sell
2,668
-556
-17% -$49.9K 0.01% 694
2024
Q1 		$306K Buy
3,224
+719
+29% +$66.7K 0.01% 605
2023
Q4 		$224K Sell
2,505
-2,563
-51% -$190K 0.01% 648
2023
Q3 		$370K Buy
5,068
+474
+10% +$37.9K 0.02% 503
2023
Q2 		$383K Buy
4,594
+1,070
+30% +$89.5K 0.02% 503
2023
Q1 		$268K Buy
3,524
+422
+14% +$35K 0.01% 575
2022
Q4 		$257K Buy
+3,102
New +$251K 0.01% 586
2022
Q1 		– Sell
-2,319
Closed -$273K – 636
2021
Q4 		$273K Sell
2,319
-605
-21% -$73K 0.02% 508
2021
Q3 		$367K Sell
2,924
-356
-11% -$45.8K 0.03% 423
2021
Q2 		$445K Sell
3,280
-1,116
-25% -$147K 0.03% 376
2021
Q1 		$596K Sell
4,396
-2,117
-33% -$317K 0.06% 271
2020
Q4 		$917K Buy
6,513
+3,128
+92% +$401K 0.09% 195
2020
Q3 		$378K Sell
3,385
-7,025
-67% -$788K 0.05% 293
2020
Q2 		$1.17M Buy
10,410
+5,589
+116% +$550K 0.19% 134
2020
Q1 		$373K Buy
+4,821
New +$427K 0.1% 213

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Great Valley Advisor Group's XBI Position: Q1 2026 in Review

Great Valley Advisor Group increased its State Street SPDR S&P Biotech ETF (XBI) stake by 9.8% in Q1 2026, buying an estimated $31.7K and bringing the position to 2,834 shares worth $362K. The position accounts for 0.01% of the portfolio, ranked #766.

Great Valley Advisor Group first reported a position in XBI in Q1 2020 and has held it in 22 quarters since. The position peaked at $1.17M in Q2 2020. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Great Valley Advisor Group held 2,834 shares of State Street SPDR S&P Biotech ETF worth $362K as of Q1 2026.
  • Great Valley Advisor Group bought 254 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $31.7K.
  • State Street SPDR S&P Biotech ETF made up 0.01% of Great Valley Advisor Group's portfolio in Q1 2026, its #766 holding.
  • Great Valley Advisor Group first reported a position in State Street SPDR S&P Biotech ETF in Q1 2020 and has held it in 22 quarters since.
  • Great Valley Advisor Group's State Street SPDR S&P Biotech ETF position peaked at $1.17M in Q2 2020.
  • 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Great Valley Advisor Group's 13F filing for Q1 2026, filed 11 May 2026.